InnovaRx Innova Health Strategies

D29.20

Benign neoplasm of unspecified testis

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 2 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Instructional notes 10
D29code
Includes
  • benign neoplasm of skin of male genital organs
D29.2code
Use additional code
  • code to identify any functional activity.
C00-D49chapter
Notes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 10
  • Sertoli cell
    • adenoma
      • unspecified site
    • tumor
      • with lipid storage
        • unspecified site
      • unspecified site
  • Adenoma — see also Neoplasm, benign, by site
    • rete cell D29.20
    • Sertoli cell
      • unspecified site
    • testicular
      • unspecified site
    • tubular — see also Neoplasm, benign, by site
      • Pick's
        • unspecified site
    • Pick's tubular
      • unspecified site
  • Teratoma (solid) — see also Neoplasm, uncertain behavior, by site
    • testis C62.9
      • adult, benign, cystic, differentiated type or mature D29.2
  • Androblastoma
    • tubular
      • with lipid storage
        • unspecified site
      • unspecified site
    • benign
      • unspecified site
  • Arrhenoblastoma
    • benign
      • unspecified site
  • Leydig cell
    • tumor
      • benign
        • unspecified site
  • Tumor — see also Neoplasm, unspecified behavior, by site
    • Leydig cell — see Neoplasm, uncertain behavior, by site
      • benign — see Neoplasm, benign, by site
        • unspecified site
    • Sertoli cell — see Neoplasm, benign, by site
      • with lipid storage
        • unspecified site
      • unspecified site
    • Sertoli-Leydig cell — see Neoplasm, benign, by site
      • unspecified site
  • Folliculome lipidique
    • unspecified site
  • Leydig-Sertoli cell tumor
    • unspecified site
  • Sertoli-Leydig cell tumor — see Neoplasm, benign, by site
    • unspecified site
Alongside this code 2 same parent — D29.2
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
D29.2
Block
D10-D36
Siblings
2

Present FY2024–FY2027.